Furthermore, we examined whether linagliptin affected α cell function, and found that linagliptin significantly up-regulated the relative production of GLP-1 vs glucagon in α cells of both non-diabetic and diabetic human islets, which would be beneficial for restoring normoglycemia in diabetes treatment. Here, GCG is linked to diabetes mellitus.